Drug Type Small molecule drug |
Synonyms 1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid, 1-Methyl-5-p-toluoylpyrrole-2-acetic acid, 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid + [7] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (24 Mar 1976), |
Regulation- |
Molecular FormulaC15H19NNaO5 |
InChIKeyAMCYRKBALHFTGR-UHFFFAOYSA-N |
CAS Registry64490-92-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00158 | Tolmetin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Juvenile Idiopathic Arthritis | US | 29 Apr 1988 | |
Osteoarthritis | US | 24 Mar 1976 | |
Rheumatoid Arthritis | US | 24 Mar 1976 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | GALT Pharmaceuticals LLCStartup | 29 Apr 2024 |
Pain | Preclinical | US | GALT Pharmaceuticals LLCStartup | 29 Apr 2024 |